Science

Feb 25, 2025, 10:52

Liquid Biopsy in Clinical Practice: Past, Present and Future – ISLB

International Society of Liquid Biopsy shared an article by Jinghan Song, et al. on X:

“Liquid Biopsy in Clinical Practice: Past, Present & Future.

A new review explores the evolution, applications, and future directions of liquid biopsy in oncology. Here are the key insights:

Technologies & Biomarkers:

Circulating Tumor Cells (CTCs) – Enrichment & detection methods (PCR, IHC, FISH, scRNA-seq).
Circulating Tumor DNA (ctDNA) – PCR & NGS-based detection for genomic alterations.
Exosomes – Advanced methods for isolating tumor-derived extracellular vesicles.

Clinical Applications:

Early Cancer Detection – Liquid biopsy enhances non-invasive screening.
Cancer Staging & Prognosis – Stratifies patients based on risk & molecular profiling.
Therapy Guidance – Detects actionable mutations like ESR1, PIK3CA, EGFR, ALK for precision medicine.
Treatment Response Monitoring – Tracks minimal residual disease (MRD) & therapy resistance.

Advancing Liquid Biopsy for Multi-Cancer Screening.

Emerging multi-cancer detection technologies: CCGA3, CancerSEEK, THUNDER, DETECT-A, PATHFINDER.
AI & machine learning integration for enhanced diagnostic accuracy.

Future Directions:

Standardization & Validation – Steps to clinical utility.
Multi-Omics Approach – Integrating genomics, transcriptomics, and proteomics.
Ex Vivo Models – Using CDX mouse models for precision therapy testing.

Liquid biopsy is revolutionizing oncology—enhancing early detection, personalized treatment & real-time monitoring.

Read the full study.”

Liquid Biopsy in Clinical Practice: Past, Present and Future - ISLB

Liquid biopsy entering clinical practice: Past discoveries, current insights, and future innovations.

Authors: Jinghan Song, et al.

Liquid Biopsy in Clinical Practice: Past, Present and Future - ISLB

cancer circulating tumor cells Circulating tumor DNA ctDN EGFR Exosomes fight against cancer Global fight against cancer International Society of Liquid Biopsy ISLB Jinghan Song liquid biopsy OncoDaily Oncology

Does Artificial Sweeteners Cause Cancer? Myths and Facts

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram